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Abstract: We have shown that Atp10c, a type 4 P-type ATPase, is a strong candidate affecting glucose and lipid 
metabolism in humans and mice. Atp10c is a putative phospholipid translocase associated with cell signaling and 
intracellular protein trafficking. In order to examine the biological role of Atp10c, semiquantitative reverse transcriptase – 
polymerase chain reaction was carried out. Atp10c mRNA is expressed in 3T3-L1 cells and in primary preadipocytes and 
adipocytes generated from mice. Atp10c mRNA is regulated during fat cell differentiation and modulated by PPAR? 
agonists and antagonists as well as by hormonal factors (insulin and dexamethasone). Atp10c expression is regulated by 
both the process of adipocyte differentiation and by effectors of fat and glucose metabolism. Taken together these data 
along with the published phenotype of the Atp10c heterozygote mice suggest that ATP10C is a newly identified protein 
with a possible biological role in the development of obesity and obesity-related metabolic disorders. 
1. INTRODUCTION 
 Studies in yeast demonstrate that members of a novel 
type 4 subfamily of P-type ATPases are important in protein 
trafficking in the exocytic and endocytic pathways. These 
putative phospholipid translocases (PLTs), or flippases, 
presumably function to control cellular integrity and homeo-
stasis by maintaining the lipid bilayer [1-4]. PLTs have been 
implicated in the translocation of phospholipids from the 
outer leaflet to the inner leaflet of lipid bilayers. Mutations in 
the sequences of mammalian flippases show their association 
with human disorders of intramembranous transport. For 
instance, mutations in human ATP8B1 are associated with 
Byler disease, which is a severe inherited disease of the liver. 
Studies in mice show that a deficiency of Atp8b1 causes a 
loss of phospholipid asymmetry, which subsequently impairs 
bile salt transport and causes cholestasis [4-7]. Another 
member of this subfamily, the murine gene Atp10d, has been 
mapped within a quantitative trait locus (QTL) associated 
with HDL-cholesterol levels in the C57BL/6 strain of mice 
[8]. Although there is consensus on the physiological 
function for PLTs, the molecular and cellular mechanisms by 
which these proteins function are poorly understood. 
 Atp10c is a putative PLT located on mouse chromosome 
7 that has been associated with obesity, type 2 diabetes, and 
nonalcoholic fatty liver disease in mice. Heterozygous mice 
inheriting a maternal deletion of the Atp10c gene become 
obese and show hyperinsulinemia, glucose intolerance, and 
insulin resistance. Mutants show a 30-35% decrease in 
insulin-stimulated glucose uptake in the peripheral tissues. 
Gene expression profiling shows a dramatic, diet-induced 
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along with subtle changes in adipocytes. Significant changes 
in the biochemical and molecular response of fat and muscle 
tissues in Atp10c mutants indicate an important role of 
ATP10C in the insulin signaling pathways that mediate 
glucose clearance by peripheral tissues [9-11]. We have also 
identified and characterized the human ortholog, ATP10C, 
and have mapped it to the syntenic region on chromosome 
15, HSA 15 [12]. A group of neurologically affected patients 
with the additional phenotype of increased body mass index 
who carry deletions in this region has also been reported, 
thus suggesting an association of Atp10c/ATP10C with some 
forms of glucose and lipid metabolism disorders in both 
mice and humans [13-15]. In general, data suggest a 
probable interaction between PLTs and obesity and insulin 
resistance, clearly emphasizing the importance of investiga-
ting their exact biological role(s). 
 In the study of metabolic diseases, the ability to 
distinguish between primary and secondary effects is a major 
problem. Given that Atp10c heterozygote mice are obese and 
exhibit metabolic abnormalities, it is difficult to understand 
if changes in glucose and lipid metabolism directly arise 
from alterations in ATP10C activity or if they are due to 
secondary complications. Thus, the present study was 
initiated to define the functional importance of Atp10c in a 
cell. Our objective was two-fold: to establish a cell system 
expressing Atp10c, then to use this cell system to identify 
factors modulating Atp10c mRNA expression. 3T3-L1 cells, 
a commercially available mouse cell line [16], and purified 
preadipocytes and adipocytes from wild-type mouse fat 
tissue were used.  
2. MATERIALS AND METHODS 
2.1 Materials 
 Cell culture reagents and oligonucleotides were obtained 
from Fisher Scientific (Fairlawn, NJ). Insulin, isobutyl-
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methylxanthine, isoproterenol, dexamethasone, all-trans 
retinoic acid, and fetal bovine serum were purchased from 
Sigma (St. Louis, MO). Thiazolidinediones MCC555 and 
troglitazone (TGZ) and the PPAR? inhibitor GW9662 were 
obtained from Cayman (Ann Arbor, MI). 
2.2 Cell Culture 
 3T3-L1 preadipocytes obtained from ATCC (Manassas, 
VA) were grown at 37ºC in 5% CO2 in Dulbecco’s modified 
Eagle’s medium containing 10% fetal bovine serum and 1% 
penicillin/streptomycin (growth medium). At 70?80% conf-
luency, adipocyte differentiation was induced by incubating 
the cells in growth medium supplemented with 0.5 mM 
isobutylmethylxanthine, 1 μM dexamethasone, and 1 μg/ml 
insulin (differentiation medium) for two days. After 2 days, 
cells were maintained in growth medium supplemented with 
1 μg/ml insulin (maintenance medium) and grown for 7-10 
days; the medium was changed every two to three days. 
Cells were fully differentiated (>80%) by day 8-10 as 
assessed by Oil Red O staining and reverse transcriptase 
PCR (RT-PCR); these are 3T3-L1 adipocytes. Day 0 
represents the day on which the differentiation media is 
replaced by maintenance media. 
 Confluent 3T3-L1 preadipocytes or adipocytes were 
incubated for 24 hours in serum-free medium before various 
effectors were added as described in the figure legends. 
PPAR? agonists and antagonists were replenished every time 
the media was changed. 
 Primary preadipocytes and adipocytes were isolated  
from adipose tissue of 4-6 month old adult female wild-type 
mice from ongoing crosses of Atp10c heterozygotes, using 
Rodbell’s procedure with modifications [17, 18]. Approxi-
mately 2 g of tissue was collected, minced into small pieces, 
and digested with collagenase (2 g/L) (type I, Worthington 
Biochemical Corp., Lakewood, NJ) at 37ºC for 25 min in 
modified Krebs-Ringer bicarbonate albumin buffer pH 7.4, 
containing 1 g/L BSA and 4.4 mM glucose. Digested fat 
tissue was filtered through a 100 μm nylon mesh and pri-
mary adipocytes were isolated by a low speed centrifugation 
at 800 rpm for 10 min. These adipocytes were washed once 
with Hank’s balanced salt solution and collected. The 
stromal vascular fraction rich in primary preadipocytes was 
then pelleted by centrifugation at 1500 rpm for 15 min. 
Resulting stromal vascular fraction cell pellets were treated 
with red blood cell lysis buffer (eBioscience, San Diego, 
CA) for 5 min at room temperature, rinsed with phosphate 
buffered saline supplemented with 1% BSA, and centrifuged 
at 800 rpm for 10 min. Stromal vascular fraction cells were 




 At 70?80% confluency, primary preadipocytes in the 
stromal vascular fraction cells were induced to differentiate 
in growth medium supplemented with 10 μg/ml insulin (high 
insulin medium). Differentiation was complete in 8?10 days 
as assessed by Oil Red O staining and RT-PCR. These cells 
are the primary adipocytes obtained from primary preadi-
pocytes differentiated in culture.  
 All animal procedures were in accordance with the 
University of Tennessee IACUC (protocol #1309-1206). 
2.3 Oil Red O Staining 
 Adipocyte differentiation was assessed using a modified 
procedure of Oil Red O staining [19]. Cells were washed 
with Hank’s balanced salt solution and fixed with 1% 
paraformaldehyde for 5 min. Cells were rinsed with 
deionized water followed by the addition of two aliquots of 
85% propylene glycol for 5 min each. Oil Red O stain was 
added (0.7% w/v in 85% propylene glycol) and cells were 
gently swirled for 20 min at room temperature. Following a 
final wash with 85% propylene glycol for 3 min, cells were 
counterstained with hematoxylin. They were visualized and 
photographed using a Zeiss Invertoskop 40C microscope 
under 10X magnification and captured by a Canon 
Powershot A620 digital camera. 
2.4 Semiquantitative RT-PCR 
 These procedures are as previously described with a few 
modifications [10]. Total RNA was extracted from the har-
vested cells using RNeasy Mini RNA kit (Qiagen Inc. 
Valencia, CA) according to the manufacturer’s instructions. 
About 1x10
6
 cells yield 30?50 μg of total RNA. First strand 
cDNA was synthesized using the iScript cDNA synthesis kit 
(Bio-Rad, Hercules, CA). Semiquantitative RT-PCR was 
performed for Atp10c (F?5?CCTGTGCTCTTCATTCTG 
GC3?, R?5?CACTGCAGCTGTGAATCTGT3?), resis-tin 
(F?5?ACTGAGTTGTGTCCTGCTAAG3?, R?5?CCACGCT 
CACTTCCCCGACATC3?), and PPAR? (F?5?GGTGAA 
ACTCTGGGAGATTC3?, R?5?CAACCATTGGGTCAGCT 
CTT3?) mRNAs using GoTaq? Green Master Mix (Promega 
Inc. Madison, WI) with ?-actin (F?5?ATGGGTCAGAAGG 
ACTCCTA3?, R?5?CAACATAGCACAGCTTCTCT3?) as 
an internal control. RT-PCR was performed under the follo-
wing conditions: 5 min at 94°C followed by 30 cycles of 
denaturation at 94°C for 30 s, annealing at 54°C for 30 s, and 
extension at 72°C for 30 s, and finishing with 5 min at 72°C. 
RT-PCR products were analyzed on 1% agarose gels con-
taining 1 μg/μl ethidium bromide and viewed under ultra-
violet light. 
2.5 Data Analysis 
 RT-PCR products on the agarose gels were quantitated 
using Scion Image (http://www.scioncorp.com). Results are 
expressed as the ratio of the target gene expression to that of 
?-actin and are shown as means ± SD. Mean comparisons 
were tested by two-tailed unpaired Student’s t-test with P 
values <0.01 considered highly significant and <0.05 
considered significant. 
3. RESULTS 
 Using RT-PCR, an 886 bp product was detected in both 
the undifferentiated and differentiated 3T3-L1 cells. This 
product has been demonstrated and confirmed to be a part of 
Atp10c cDNA [11]. Quantitative analysis showed that 
Atp10c is 2-fold down-regulated in 3T3-L1 adipocytes after 
differentiation (Fig. 1). Atp10c mRNA is also expressed in 
purified preadipocytes and adipocytes from mouse adipose 
tissue and in primary preadipocytes differentiated in culture 
(Fig. 2). Compared to primary preadipocytes, Atp10c mRNA 
is significantly down-regulated in primary adipocytes, again 
confirming the regulation of Atp10c expression during 
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adipogenesis. As expected, PPAR? (PCR product of size 
268bp) and resistin (PCR product of size 386bp) are up-
regulated, serving as internal positive controls (Fig. 2A).  
 Adipose tissue is comprised of several types of cells such 
as  fibroblasts, non-differentiated mesenchymal cells, preadi- 
pocytes, and adipocytes. Adipocytes develop from fibro-
blast-like preadipocytes within the stromal vascular fraction 
[20, 21]. Hence, to ensure that stromal vascular fraction cells 
in our preparations were comprised mainly of preadipocytes 
and that Atp10c expression was specific to the preadipocyte 
fraction, we differentiated the stromal vascular fraction cells 
to adipocytes, and then measured Atp10c expression. 
Interestingly, Atp10c expression was about 2-fold up-
regulated whereas, PPAR? and resistin expressions were 
 
Fig. (1). Atp10c mRNA is expressed in 3T3-L1 cells. Atp10c (A), resistin (B), and PPAR? (C) expression was examined by RT-PCR in 3T3-
L1 preadipocytes (PA) and adipocytes (Ad); ?-actin served as an internal control. Expression of Atp10c, PPAR? and resistin mRNAs is 
denoted as arbitrary units (A.U.) and represented as normalized to ?-actin. Data from four independent experiments are shown. ***P<0.001. 
Lack of PCR products due to low levels of expression are denoted as not detected (ND).  
   
 
Fig. (2). Atp10c mRNA is expressed in primary preadipocytes and adipocytes. RT-PCR analysis was used to determine Atp10c, resistin, and 
PPAR? expression in primary preadipocytes (PA) and adipocytes (Ad) purified from mouse adipose tissue (A); ?-actin served as an internal 
control. Expressions are denoted as arbitrary units (A.U.) and represented as normalized to ?-actin. Data from four independent experiments 
are shown. ***P<0.001. Lack of PCR products due to low levels of expression are denoted as not detected (ND).  
RT-PCR analysis was used to determine Atp10c expression in primary preadipocytes (PA) and adipocytes (Ad) harvested from culture (B); 
?-actin served as an internal control. Expression is denoted as arbitrary units (A.U.) and represented as normalized to ?-actin. Data from four 
independent experiments are shown. ***P<0.001.  
Oil Red O staining (C) was used to monitor and confirm differentiation of primary preadipocytes (PA) to adipocytes (Ad) in culture. A 
representative image from four independent experiments is shown. 
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significantly down-regulated (Fig. 2B). PPAR? and resistin 
mRNA expressions were very low in primary preadipocytes 
and after differentiation no PCR product was detected in 
primary adipocytes. As described below, we believe that this 
increase in Atp10c expression and the corresponding dec-
rease in PPAR? and resistin expressions in primary adipo-
cytes are due to high insulin present in the differentiation 
media used for primary cultures. Oil Red O staining was 
used to monitor differentiation in culture and to confirm that 
the harvested cells showed >80% differentiation (Fig. 2C). 
 The process of adipocyte differentiation is associated 
with a large number of cis -and trans-acting factors [22-24]. 
The regulation of different genes at distinct times after the 
exposure of cells to differentiation conditions suggests the 
existence of a regulatory hierarchy or cascade of events [25, 
26]. PPAR? is considered to be the master regulator of adi-
pogenesis, controlling the expression of adipocyte genes. 
Therefore, we investigated the effect of PPAR? agonists on 
Atp10c expression to assess whether Atp10c expression is 
also under PPAR? control. Two anti-diabetic drugs that acti-
vate PPAR? and thus promote adipogenesis, MCC555 and 
TGZ, were used [27, 28]. 3T3-L1 adipocytes were treated 
with these reagents as described in materials and methods 
and in figure legends. As demonstrated by RT-PCR and Oil 
Red O staining, both MCC555 and TGZ promoted adipoge-
nesis and consequently reduced Atp10c expression by 5-fold 
and 3-fold respectively (Fig. 3). This significant decrease in 
adipocytes further confirms the pattern of Atp10c expression 
in differentiated cells. 
 To clarify and confirm that the decrease in Atp10c is 
indeed due to the process of adipogenesis controlled by 
PPAR?, Atp10c expression was also assessed in cells treated 
with a PPAR? antagonist, GW9662 [29]. Atp10c expression 
in adipocytes treated with GW9662 alone did not decrease 
significantly and was similar to that in control cells treated 
with the vehicle DMSO. However, when GW9662 was 
added to the cells along with MCC555 or TGZ, there was 
only about a 2-fold decrease in Atp10c expression. This 
suggests that GW9662 inhibited adipogenesis and rescued 
some of the decrease in Atp10c expression due to MCC555 
or TGZ alone. Similarly, Atp10c expression did not decrease 
 
Fig. (3). Atp10c mRNA expression is regulated by PPAR? agonists and antagonists. RT-PCR analysis shows Atp10c expression in 3T3-L1 
adipocytes harvested between days 8?10 of differentiation. MCC555, troglitazone (TGZ), and GW9662 were added to the media throughout 
the differentiation process and replenished whenever the media was changed. Expression of Atp10c mRNA in adipocytes treated with 10μM 
DMSO (vehicle), 10μM MCC555, 10μM TGZ, and 10μM GW9662 is shown (A), with ?-actin serving as an internal control. The expression 
of Atp10c is denoted as arbitrary units (A.U.) and represented as the fold change normalized to ?-actin. Oil Red O staining (B) was used to 
monitor morphological changes in adipocytes in the presence of PPAR? agonists and antagonists. Data from six independent experiments are 
shown. *P<0.05, ***P<0.001. 
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following treatment of adipocytes with 1 μM all-trans 
retinoic acid (data not shown). 1 μM all-trans retinoic acid 
also inhibits adipocyte differentiation thus, confirming that 
Atp10c is highly expressed in undifferentiated cells and 
negatively regulated during adipocyte differentiation. 
 To gain further insight into the transcriptional control of 
Atp10c during adipogenesis Atp10c expression was com-
pared to that of PPAR? in cells treated with MCC555 or a 
combination of MCC555 and GW9662 and harvested at days 
1, 2, 4, and 7 post-induction (Fig. 4). High levels of Atp10c 
were expressed at day 1 that gradually decreased through 
days 2-7 (Fig. 4A). When >80% of preadipocytes were diffe-
rentiated into adipocytes at day 7, Atp10c expression was 2-
fold down-regulated, supporting our observations described 
in Fig. (1). As expected, PPAR? expression increased sig-
nificantly through days 1?7 (Fig. 4B). Oil Red O staining 
was carried out to monitor the differentiation process (Fig. 
4C).  
 Since Atp10c was expressed and levels were modulated 
during the differentiation of 3T3-L1 preadipocytes to 
adipocytes, we next investigated the regulation of Atp10c 
mRNA expression by effector molecules of glucose and fat 
metabolism in undifferentiated and differentiated cells. This 
was examined by incubating cells with 100 nM insulin, 100 
nM dexamethasone, or 100 nM isoproterenol for 24 hours. 
Atp10c mRNA increased 4-fold or 6-fold, respectively, when 
insulin or dexamethasone was added to 3T3-L1 adipocytes; 
there was no significant change in preadipocytes. As 
expected, resistin and PPAR? mRNAs decreased following 
treatment with insulin or dexamethasone (Fig. 5). Based on 
these results, we believe that the up-regulation of Atp10c and 
the down regulation of PPAR? and resistin observed in 
primary adipocytes differentiated in culture (Fig. 2B) are due 
to the high insulin used in the differentiation media. 
 Atp10c mRNA expression slightly decreased after 
incubating the cells with 100 nM isoproterenol, but this was 
not statistically significant (data not shown). 
4. DISCUSSION 
 Protein trafficking and intracellular signaling processes 
are important in controlling cellular homeostasis. Defects in 
 
Fig. (4). Atp10c and PPAR? mRNAs are oppositely regulated in 3T3-L1 cells during adipogenesis. RT-PCR analysis was used to determine 
Atp10c (A) and PPAR? (B) mRNA expression in 3T3-L1 cells at days 1, 2, 4, and 7 post-induction; ?-actin served as an internal control. 
Cells were treated throughout differentiation with DMSO, MCC555, or a combination of GW9662 and MCC555. Expression of Atp10c and 
PPAR? mRNA is denoted as arbitrary units (A.U.) and represented as the fold change normalized to ?-actin and compared to day 1 DMSO. 
Oil Red O staining (C) was used to assess the corresponding morphological changes. Data from five independent experiments are shown. 
*P<0.05, **P<0.005, ***P<0.001. 
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these processes can lead to changes in cellular function 
resulting in serious pathological conditions like obesity and 
type 2 diabetes [30, 31]. Although numerous target genes 
and their cognate protein factors have been identified and 
their roles characterized, our understanding of these pro-
cesses is still limited. It is probable that many components of 
the system are still unidentified. Hence, novel factors are 
continually being identified and strategies to further our 
understanding of mechanisms underlying the above pro-
cesses are being developed. 
 Type 4 P-type ATPases belong to a newly identified 
subfamily of PLTs in eukaryotes. They are suggested to 
maintain the asymmetrical nature of the lipid bilayer and are 
proposed to be important in protein trafficking [1,3,5]. These 
ATPases are thought to catalyze the transbilayer transport of 
amphipathic molecules such as phospholipids, rather than 
being pumps for the transfer of cations [32-35]. Based on 
published reports from our laboratory, it is reasonable to 
suggest that Atp10c/ATP10C, one member of this subfamily, 
may play an important role in obesity of multiple etiologies 
in mice and humans. 
 Mice heterozygous for Atp10c, a putative PLT, represent 
a diet-induced genetic model of obesity associated with 
insulin resistance. Prior studies suggest that misexpression of 
Atp10c promotes obesity by modulating glucose and lipid 
metabolism [9, 10]. To gain mechanistic insight into the link 
between the translocase activities of PLTs and metabolic 
diseases, in the current report we have successfully estab-
lished cell culture systems which express Atp10c and thus, 
will be used to study its functional role(s) in insulin signaling 
and adipogenesis.  
 We show for the first time here that Atp10c mRNA is 
expressed in the undifferentiated and differentiated adipo-
cytes both in vitro and ex vivo. We also demonstrate changes 
in Atp10c expression during adipose cell differentiation. 
Finally, we report that Atp10c expression in 3T3-L1 adipo-
cytes is significantly altered by peroxisome proliferator-
activated receptor-? (PPAR?) agonists and antagonists as 
well as by the hormonal factors insulin and dexamethasone. 
A solid understanding of Atp10c mRNA will now assist in 
the future studies to understand the regulation of ATP10C 
protein. 
 Adipocyte differentiation involves a temporally regulated 
set of gene expression events, and understanding the under-
lying transcriptional networks is of fundamental importance 
to adipocyte biology. PPAR?, a member of the nuclear-
receptor superfamily, is considered as a master regulator of 
adipogenesis. It is both necessary and sufficient for adipoge-
nesis. Numerous pro- and anti-adipogenic factors work via 
PPAR? to activate or repress adipocyte differentiation [36, 
37]. Almost every important cellular signaling pathway 
exerts a positive or negative effect on adipocyte development 
via factors that are still poorly understood. As a result, the 
identification and characterization of novel factors affecting 
these processes is ongoing. 3T3-L1 cells are being used 
extensively as an in vitro model and primary cultures derived 
from mouse adipose tissue as an ex vivo model to study the 
cellular and molecular aspects of adipocyte differentiation. 
 Interestingly, our data also shows that Atp10c is a novel 
factor negatively regulated during adipogenesis. We have 
shown that Atp10c mRNA is significantly down-regulated by 
the process of adipocyte differentiation and that these 
changes are not due to any experimental manipulation of the 
 
Fig. (5). Atp10c mRNA expression is regulated conversely to that of PPAR? and resistin mRNAs in 3T3-L1 adipocytes following treatment 
with hormonal factors. RT-PCR analysis was used to determine Atp10c (A), PPAR? (B) and resistin (C) mRNA expressions in untreated 
3T3-L1 adipocytes (CON), and following treatment with 100 nM insulin (INS) or 100 nM dexamethasone (DEX) for 24 hours. ?-actin is 
used as an internal control. Expression is denoted as arbitrary units (A.U.) and represented as the fold change normalized to ?-actin. Data 
from four independent experiments are shown. ***P<0.001.  
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cells in culture. The differential expression of Atp10c in 
preadipocytes and adipocytes is an example of cell type-
specific expression similar to that of pref-1, where the gene 
is active in preadipocytes and is repressed in adipocytes [38]. 
Atp10c may be an important component of preadipocytes, 
functioning to maintain a preadipose state or to prepare the 
cells for the process of differentiation. The exact role of 
Atp10c in adipogenesis is not known at this time; however, 
our data clearly establishes a pattern completely opposite to 
that of PPAR? and some other well-characterized obesity 
genes like resistin. Our data suggests a regulatory control of 
Atp10c transcription during adipocyte development and 
lends further support to the use of the 3T3-L1 cell line. 
Specific experiments to study translational control and the 
effect of ATP10C - silencing or - overexpression on the 
other obesity/diabetes genes can now be accomplished. 
 PPAR?  agonists, such as thiazolidinediones, promote adi-
pocyte differentiation and have insulin-sensitizing effects in 
animals and diabetic patients [25-27]. Conversely, the 
PPAR?-specific antagonist GW9662 has been shown to 
inhibit adipogenesis and has been successfully used to study 
the regulation of gene expression during 3T3-L1 adipocyte 
differentiation [29]. Similarly, retinoic acid prevents and 
antagonizes PPAR? gene expression and is shown to be an 
inhibitor of adipocyte differentiation [39]. Thus, down-regu-
lation of Atp10c expression by the PPAR? agonists MCC555 
and TGZ along with restoration of Atp10c expression by 
PPAR? antagonists GW9662 and retinoic acid, suggest a 
possible relationship between PPAR??mediated adipoge-
nesis and Atp10c transcription. Whether a similar association 
exists between adipogenesis and ATP10C translation is to be 
determined. 
 Finally, our results also suggest transcriptional control of 
Atp10c expression by the hormonal factors insulin and 
dexamethasone during differentiation. Insulin is already 
known to regulate a number of mRNAs coding for obesity 
and diabetes genes [39, 40]. Hence, in this study, we prove 
that insulin regulates yet another novel gene, Atp10c, again 
suggesting it to be important in insulin signaling processes. 
Dexamethasone induces insulin resistance and stimulates 
Atp10c production, which is similar to its effect on ob gene 
expression and leptin production [41]. In contrast, lack of a 
significant effect by isoproterenol suggests that Atp10c 
expression is not controlled by adrenoceptors in 3T3-L1 
adipocytes [42]. 
 In summary, the results of this study strengthen our 
earlier hypotheses that Atp10c has a putative role in glucose 
and lipid metabolism. However, the exact mechanism is still 
unknown. Even though we have not yet proved our hypo-
theses we have certain clues to demonstrate that when the 
adipocytes are treated with dexamethasone, which is known 
to induce insulin resistance, Atp10c expression increases 
(Fig. 5), suggesting that an increased Atp10c expression 
might result in a loss of insulin sensitivity. If this is proved 
correct then conversely, a decrease in Atp10c expression 
should decrease insulin resistance thereby improve insulin 
sensitivity? This is supported by the expression patterns 
observed in presence of TZDs (Fig. 4).  
 In all types of obesity and type 2 diabetes, the major 
abnormality lies in the glucose uptake system. In peripheral 
tissues, insulin-stimulated glucose uptake is dependent upon 
the translocation of insulin-responsive glucose transporter 
GLUT4 from intracellular storage compartments, the trans -
Golgi network to the plasma membrane. Membrane 
trafficking of GLUT4 is a complex phenomenon involving 
three major steps — insulin signaling to GLUT4 vesicles, 
trafficking of GLUT4 vesicles to the plasma membrane and 
finally docking and fusion of GLUT4 vesicles with the 
plasma membrane [43, 44]. In view of our data, it is 
conceivable that the translocase activities of ATP10C protein 
mediate GLUT4 translocation at any one of these steps. 
Changes in Atp10c gene expression might affect the surface 
properties, membrane curvature, vesicle formation, fusion, or 
bilayer thickness/fluidity of the plasma membrane thereby 
affecting the trafficking and/or biogenesis of glucose trans-
porters. Focused, hypothesis-driven experiments to address 
these questions can now be initiated in our cell systems. 
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